Canlyniadau Chwilio - Hiroyoshi Nishikawa

Mireinio'r Canlyniadau
  1. 1
    In vivo antigen delivery by aSalmonella typhimurium type III secretion system for therapeutic cancer vaccines

    In vivo antigen delivery by aSalmonella typhimurium type III secretion system for therapeutic cancer vaccines gan Hiroyoshi Nishikawa

    Cyhoeddwyd 2006
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  2. 2
    Regulatory T cells in tumor immunity

    Regulatory T cells in tumor immunity gan Hiroyoshi Nishikawa, Shimon Sakaguchi

    Cyhoeddwyd 2010
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  3. 3
    Roles of regulatory T cells in cancer immunity

    Roles of regulatory T cells in cancer immunity gan Yoshiko Takeuchi, Hiroyoshi Nishikawa

    Cyhoeddwyd 2016
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  4. 4
    Regulatory T cells: a potential target in cancer immunotherapy

    Regulatory T cells: a potential target in cancer immunotherapy gan Kohei Shitara, Hiroyoshi Nishikawa

    Cyhoeddwyd 2018
    Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  5. 5
    Regulatory T (Treg) cells in cancer: Can Treg cells be a new therapeutic target?

    Regulatory T (Treg) cells in cancer: Can Treg cells be a new therapeutic target? gan Yoshihiro Ohue, Hiroyoshi Nishikawa

    Cyhoeddwyd 2019
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  6. 6
    Mechanisms of regulatory T cell infiltration in tumors: implications for innovative immune precision therapies

    Mechanisms of regulatory T cell infiltration in tumors: implications for innovative immune precision therapies gan Shohei Koyama, Hiroyoshi Nishikawa

    Cyhoeddwyd 2021
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  7. 7
    Engineering strategies for broad application of TCR-T- and CAR-T-cell therapies

    Engineering strategies for broad application of TCR-T- and CAR-T-cell therapies gan Keisuke Watanabe, Hiroyoshi Nishikawa

    Cyhoeddwyd 2021
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  8. 8
    Natural and Induced T Regulatory Cells in Cancer

    Natural and Induced T Regulatory Cells in Cancer gan Dennis O. Adeegbe, Hiroyoshi Nishikawa

    Cyhoeddwyd 2013
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  9. 9
    Transcriptional regulatory network for the establishment of CD8+ T cell exhaustion

    Transcriptional regulatory network for the establishment of CD8+ T cell exhaustion gan Wooseok Seo, Chandsultana Jerin, Hiroyoshi Nishikawa

    Cyhoeddwyd 2021
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  10. 10
    Metabolic advantages of regulatory T cells dictated by cancer cells

    Metabolic advantages of regulatory T cells dictated by cancer cells gan Masaki Kondo, Shogo Kumagai, Hiroyoshi Nishikawa

    Cyhoeddwyd 2023
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  11. 11
    A mixture-of-experts deep generative model for integrated analysis of single-cell multiomics data

    A mixture-of-experts deep generative model for integrated analysis of single-cell multiomics data gan Kodai Minoura, Ko Abe, Hyunha Nam, Hiroyoshi Nishikawa, Teppei Shimamura

    Cyhoeddwyd 2021
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  12. 12
    Reprogramming the Tumor Microenvironment to Improve Immunotherapy: Emerging Strategies and Combination Therapies

    Reprogramming the Tumor Microenvironment to Improve Immunotherapy: Emerging Strategies and Combination Therapies gan Meenal Datta, Lisa M. Coussens, Hiroyoshi Nishikawa, F. Stephen Hodi, Rakesh K. Jain

    Cyhoeddwyd 2019
    Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  13. 13
    Cancer immunotherapy with PI3K and PD-1 dual-blockade via optimal modulation of T cell activation signal

    Cancer immunotherapy with PI3K and PD-1 dual-blockade via optimal modulation of T cell activation signal gan Sho Isoyama, Shigeyuki Mori, Daisuke Sugiyama, Yasuhiro Kojima, Yasuko Tada, Kohei Shitara, Kunihiko Hinohara, Shingo Dan, Hiroyoshi Nishikawa

    Cyhoeddwyd 2021
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  14. 14
    The ratio of CD8 + lymphocytes to tumor-infiltrating suppressive FOXP3 + effector regulatory T cells is associated with treatment response in invasive breast cancer

    The ratio of CD8 + lymphocytes to tumor-infiltrating suppressive FOXP3 + effector regulatory T cells is associated with treatment response in invasive breast cancer gan Noriko Goda, Shinsuke Sasada, Hideo Shigematsu, Norio Masumoto, Koji Arihiro, Hiroyoshi Nishikawa, Shimon Sakaguchi, Morihito Okada, Takayuki Kadoya

    Cyhoeddwyd 2022
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  15. 15
    Regulatory T Cell–Resistant CD8+ T Cells Induced by Glucocorticoid-Induced Tumor Necrosis Factor Receptor Signaling

    Regulatory T Cell–Resistant CD8+ T Cells Induced by Glucocorticoid-Induced Tumor Necrosis Factor Receptor Signaling gan Hiroyoshi Nishikawa, Takuma Kato, Michiko Hirayama, Yuki Orito, Eiichi Sato, Naozumi Harada, Sacha Gnjatic, Lloyd J. Old, Hiroshi Shiku

    Cyhoeddwyd 2008
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  16. 16
    Targeting VEGFR2 with Ramucirumab strongly impacts effector/ activated regulatory T cells and CD8+ T cells in the tumor microenvironment

    Targeting VEGFR2 with Ramucirumab strongly impacts effector/ activated regulatory T cells and CD8+ T cells in the tumor microenvironment gan Yasuko Tada, Yosuke Togashi, Daisuke Kotani, Takeshi Kuwata, E Sato, Akihito Kawazoe, Toshihiko Doi, Hisashi Wada, Hiroyoshi Nishikawa, Kohei Shitara

    Cyhoeddwyd 2018
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  17. 17
    IFN-γ Controls the Generation/Activation of CD4+CD25+ Regulatory T Cells in Antitumor Immune Response

    IFN-γ Controls the Generation/Activation of CD4+CD25+ Regulatory T Cells in Antitumor Immune Response gan Hiroyoshi Nishikawa, Takuma Kato, Isao Tawara, Hiroaki Ikeda, Kagemasa Kuribayashi, Paul M. Allen, Robert D. Schreiber, Lloyd J. Old, Hiroshi Shiku

    Cyhoeddwyd 2005
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  18. 18
    Selective inhibition of low-affinity memory CD8+ T cells by corticosteroids

    Selective inhibition of low-affinity memory CD8+ T cells by corticosteroids gan Akihiro Tokunaga, Daisuke Sugiyama, Yuka Maeda, Allison Betof Warner, Katherine S. Panageas, Sachiko Ito, Yosuke Togashi, Chika Sakai, Jedd D. Wolchok, Hiroyoshi Nishikawa

    Cyhoeddwyd 2019
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  19. 19
    Sustained inhibition of CSF1R signaling augments antitumor immunity through inhibiting tumor-associated macrophages

    Sustained inhibition of CSF1R signaling augments antitumor immunity through inhibiting tumor-associated macrophages gan Takahiko Sato, Daisuke Sugiyama, Jun Koseki, Yasuhiro Kojima, Satomi Hattori, Kazuki Sone, Hitomi Nishinakamura, Tomohiro Ishikawa, Yuichi Ishikawa, T. Kato, Hitoshi Kiyoi, Hiroyoshi Nishikawa

    Cyhoeddwyd 2025
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  20. 20
    Clinicopathological features of 22C3 PD-L1 expression with mismatch repair, Epstein–Barr virus status, and cancer genome alterations in metastatic gastric cancer

    Clinicopathological features of 22C3 PD-L1 expression with mismatch repair, Epstein–Barr virus status, and cancer genome alterations in metastatic gastric cancer gan Akihito Kawazoe, Kohei Shitara, Yasutoshi Kuboki, Hideaki Bando, Takashi Kojima, Takayuki Yoshino, Atsushi Ohtsu, Atsushi Ochiai, Yosuke Togashi, Hiroyoshi Nishikawa, Toshihiko Doi, Takeshi Kuwata

    Cyhoeddwyd 2018
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:

Offerynnau Chwilio: